1. Schering Aktiengesellschaft (29 from 1,384 patents)

2. Bayer Schering Pharma Ag (5 from 192 patents)

3. Novartis Ag (4 from 3,923 patents)

4. Other (1 from 832,880 patents)

5. Schering Aktiengellschaft (1 from 4 patents)

6. Schering Aktienegesellschaft (1 from 1 patent)

7. Bayer Pharma Aktiengesellschaft (378 patents)

1. 7906533 - Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

2. 7902229 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

3. 7615565 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

4. 7572794 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

5. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

6. 7479491 - Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors

7. 7459470 - N-oxide anthranylamide derivatives and their use as medicaments

8. 7429592 - Cyanoanthranilamide derivatives and the use thereof as medicaments

9. 7211680 - Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments

10. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones

11. 7148357 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

12. 7115758 - Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents

13. 7081468 - Ortho-substituted anthranilic acid amides and their use as medicaments

14. 7071344 - Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments

15. 7012081 - Anthranyl amides and their use as medicaments